The groundbreaking therapy of the medication represents a significant advance in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide411890.amoblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-64142043